Christopher M. Bland
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Use and Resistance 18
-
- Bacterial Identification and Susceptibility Testing 18
- Co-authors
- P. Brandon BookstaverBruce M JonesKayla R. StoverBrooke GriffinLea S. EilandMilena M. McLaughlinThomas P. LodiseManjunath P. Pai
- Journals
- Open Forum Infectious Diseases (15 papers)American Journal of Health-System Pharmacy (9 papers)JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY (6 papers)Annals of Pharmacotherapy (6 papers)Currents in Pharmacy Teaching and Learning (5 papers)
- Partner nations
- United StatesSwedenMexico
In The Last Decade
Christopher M. Bland
78 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 124
- Applied Microbiology and Biotechnology 137
- Molecular Medicine 105
- Clinical Biochemistry 130
- Pharmacology 291
- Infectious Diseases 212
Countries citing papers authored by Christopher M. Bland
This map shows the geographic impact of Christopher M. Bland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher M. Bland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher M. Bland more than expected).
Fields of papers citing papers by Christopher M. Bland
This network shows the impact of papers produced by Christopher M. Bland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher M. Bland. The network helps show where Christopher M. Bland may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher M. Bland, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 3 | |
| 8 | 2022 | 1 | |
| 9 | 2022 | 0 | |
| 10 | 2022 | 0 | |
| 11 | 2021 | 2 | |
| 12 | 2021 | 7 | |
| 13 | 2020 | 8 | |
| 14 | 2020 | 4 | |
| 15 | 2019 | 33 | |
| 16 | 2019 | 6 | |
| 17 | 2019 | 28 | |
| 18 | 2015 | 10 | |
| 19 | 2014 | 9 | |
| 20 | 1999 | 68 |
About Christopher M. Bland
Christopher M. Bland is a scholar working on Applied Microbiology and Biotechnology, Clinical Biochemistry, Molecular Medicine, Pharmacology and Geriatrics and Gerontology, having authored 89 papers that have together received 1.2k indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (18 papers), Bacterial Identification and Susceptibility Testing (18 papers), Antimicrobial Resistance in Staphylococcus (18 papers), Drug-Induced Adverse Reactions (13 papers), Antibiotics Pharmacokinetics and Efficacy (12 papers), Antibiotic Resistance in Bacteria (10 papers), Innovations in Medical Education (8 papers) and Pneumonia and Respiratory Infections (7 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (137 citations), Molecular Medicine (105 citations), Clinical Biochemistry (130 citations), Pharmacology (291 citations) and Infectious Diseases (212 citations). Christopher M. Bland has collaborated with scholars based in United States, Sweden and Mexico. Frequent co-authors include P. Brandon Bookstaver, Bruce M Jones, Kayla R. Stover, Brooke Griffin, Lea S. Eiland, Milena M. McLaughlin, Thomas P. Lodise, Manjunath P. Pai, Andrea Sikora and W. Anthony Hawkins. Their work appears in journals such as Open Forum Infectious Diseases, American Journal of Health-System Pharmacy, JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, Annals of Pharmacotherapy and Currents in Pharmacy Teaching and Learning.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.